We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

69 hedge funds and large institutions have $327M invested in Heron Therapeutics in 2014 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

414% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 7

90% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 10

73% more funds holding

Funds holding: 40 → 69 (+29)

13% more capital invested

Capital invested by funds: $289M → $327M (+$37.9M)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $12K

Holders
69
Holders Change
+29
Holders Change %
+72.5%
% of All Funds
1.98%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
36
Increased
19
Reduced
10
Closed
7
Calls
–
Puts
$12K
Net Calls
-$12K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$8.36M
2
BC
Broadfin Capital
New York
+$6.87M
3
TCM
Tang Capital Management
California
+$6.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.82M
5
BFA
BlackRock Fund Advisors
California
+$5.71M

Top Sellers

Rank Fund Capital Flow
1
ICM
ISZO Capital Management
New York
-$4.83M
2
AC
Ascend Capital
California
-$1.75M
3
DCM
Driehaus Capital Management
Illinois
-$1.73M
4
PA
Perceptive Advisors
New York
-$1.53M
5
Morgan Stanley
Morgan Stanley
New York
-$1.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$1.01M +$947K +79,263 +2,467%
AQR Capital Management
27
AQR Capital Management
Connecticut
$924K +$896K +75,000 New
TI
28
Turner Investments
Pennsylvania
$924K +$896K +75,000 New
TCIM
29
TIAA CREF Investment Management
New York
$893K +$866K +72,491 New
GTC
30
Ghost Tree Capital
New York
$862K +$836K +70,000 New
FM
31
Forward Management
California
$822K -$264K -22,093 -24%
GP
32
GLG Partners
United Kingdom
$730K -$799K -66,892 -53%
BIM
33
BlackRock Investment Management
Delaware
$673K +$653K +54,645 New
Northern Trust
34
Northern Trust
Illinois
$581K +$306K +25,654 +120%
Tudor Investment Corp
35
Tudor Investment Corp
Connecticut
$503K +$189K +15,801 +63%
Goldman Sachs
36
Goldman Sachs
New York
$493K +$277K +23,183 +138%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$437K +$424K +35,500 New
Jane Street
38
Jane Street
New York
$384K -$163K -13,615 -30%
TC
39
TFS Capital
Pennsylvania
$370K +$196K +16,406 +120%
SIM
40
Spark Investment Management
New York
$364K +$354K +29,600 New
Charles Schwab
41
Charles Schwab
California
$352K +$340K +28,500 New
TA
42
Teachers Advisors
New York
$321K +$311K +26,021 New
MLICM
43
Metropolitan Life Insurance Company (MetLife)
New York
$282K +$274K +22,917 New
SG Americas Securities
44
SG Americas Securities
New York
$252K +$244K +20,448 New
VOYA Investment Management
45
VOYA Investment Management
Georgia
$213K +$206K +17,249 New
EEG
46
E.E. Geduld
$202K -$103K -8,638 -35%
NFA
47
Nationwide Fund Advisors
Ohio
$178K +$172K +14,414 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$172K +$167K +13,950 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$166K +$161K +13,439 New
AIG
50
American International Group
New York
$163K +$157K +13,112 +10,927%
1
2
3 4

HRTX Hedge Fund Activity: Q2 2014 in Review

69 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2014, worth a combined $327M — up 13% from $289M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new HRTX positions and 7 closed out — a net gain of 29 holders — while 19 added to existing stakes and 10 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $8.36M. The largest seller was ISZO Capital Management, exiting entirely with an estimated $4.83M sold.

  • 69 institutional investors held Heron Therapeutics (HRTX) as of Q2 2014, up from 40 in Q1 2014.
  • Funds reported $327M of Heron Therapeutics stock for Q2 2014, up 13% quarter-over-quarter.
  • 36 funds opened new Heron Therapeutics positions in Q2 2014 and 7 closed out, a net change of +29 holders.
  • The largest Heron Therapeutics buyer in Q2 2014 was Cormorant Asset Management, an estimated $8.36M added.
  • The largest Heron Therapeutics seller in Q2 2014 was ISZO Capital Management, an estimated $4.83M sold.

Based on aggregated 13F filings for Q2 2014.